We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week ...

A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...

Fresenius Medical Care ( ($FMS) ) has shared an announcement. On April 1, 2025, Fresenius Medical Care successfully placed bonds totaling €1.1 ...

Fresenius, Danone and Proximus benchmarks shake off tariff turmoil ◆ Range of new issue concessions needed ◆ High orderbook attrition for those pushing hard on spread ...

The primary driver behind last 12 months revenue was the Fresenius Helios segment contributing a total revenue of €12.7b (58% ...

JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology are part of the Zacks Screen of the Week article.

The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...

Zacks Research boosted their Q1 2025 EPS estimates for shares of Fresenius Medical Care in a report released on Tuesday, ...

Fresenius said the U.S. Food and Drug Administration has approved a biologics license application for its operating company's bone-disease drugs. The approval concerns Fresenius Kabi's Conexxence ...

On March 26, 2025, the FDA approved Fresenius Kabi’s denosumab biosimilars, CONEXXENCE® (denosumab-bnht) and BOMYNTRA® (denosumab-bnht), ...

Jefferies analyst James Vane maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) today and set a price target of ...